These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 17683070)

  • 1. Colposcopy is not necessary to assess the risk to the cervix in HIV-positive women: an international cohort study of cervical pathology in HIV-1 positive women.
    Kitchener H; Nelson L; Adams J; Mesher D; Sasieni P; Cubie H; Moore C; Heard I; Agarossi A; Casolati E; Denny L; Bradbeer C; Lyons F; Beattie G; Niemiec T
    Int J Cancer; 2007 Dec; 121(11):2484-91. PubMed ID: 17683070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).
    Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT
    Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of high-grade precancerous lesions and invasive cancers in high-risk HPV-positive women with normal cervix or CIN 1 at baseline-A population-based cohort study.
    Mittal S; Basu P; Muwonge R; Banerjee D; Ghosh I; Sengupta MM; Das P; Dey P; Mandal R; Panda C; Biswas J; Sankaranarayanan R
    Int J Cancer; 2017 Apr; 140(8):1850-1859. PubMed ID: 28108997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A matched prospective study of human immunodeficiency virus serostatus, human papillomavirus DNA, and cervical lesions detected by cytology and colposcopy.
    Eckert LO; Watts DH; Koutsky LA; Hawes SE; Stevens CE; Kuypers J; Kiviat NB
    Infect Dis Obstet Gynecol; 1999; 7(3):158-64. PubMed ID: 10371475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.
    Marais DJ; Passmore JA; Denny L; Sampson C; Allan BR; Williamson AL
    J Med Virol; 2008 Jun; 80(6):953-9. PubMed ID: 18428143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of HPV testing in the follow-up of untreated cervical low grade lesions.
    Clavel C; Bory JP; Caudroy S; Lorenzato M; Durlach A; Graesslin O; Quereux C; Birembaut P
    Histol Histopathol; 2005 Oct; 20(4):1085-91. PubMed ID: 16136491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study.
    Kwan TT; Cheung AN; Lo SS; Lee PW; Tam KF; Chan KK; Ngan HY
    Acta Obstet Gynecol Scand; 2011 May; 90(5):445-51. PubMed ID: 21306349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.
    Wentzensen N; Fetterman B; Castle PE; Schiffman M; Wood SN; Stiemerling E; Tokugawa D; Bodelon C; Poitras N; Lorey T; Kinney W
    J Natl Cancer Inst; 2015 Dec; 107(12):djv257. PubMed ID: 26376685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus detection in women with low-grade squamous intraepithelial lesions or higher-grade cytology using the Cervista HPV HR test.
    Gold MA; Thomas MA; Huh WK; Sarto GE; Day SP
    J Low Genit Tract Dis; 2013 Jan; 17(1):51-7. PubMed ID: 22885641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-risk HPV detection and associated cervical lesions in a population of French menopausal women.
    Tifaoui N; Maudelonde T; Combecal J; Vallo R; Doutre S; Didelot MN; Nagot N; Segondy M; Boulle N
    J Clin Virol; 2018 Nov; 108():12-18. PubMed ID: 30196012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytology compared with Hybrid Capture 2 human papilloma virus cervical cancer screening in HIV positive and HIV negative South African women.
    Snyman LC; Richter KL; Lukhwareni A; Dreyer G; Botha MH; Van Der Merwe FH; Visser C; Dreyer G
    Int J Gynecol Cancer; 2023 May; 33(5):669-675. PubMed ID: 36650011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus absence predicts normal cervical histopathologic findings with abnormal papanicolaou smears: a study of a university-based inner city population.
    Khanna N; Brooks SE; Chen TT; Simsir A; Gordon NJ; Taylor G
    J Hum Virol; 2001; 4(5):283-7. PubMed ID: 11907386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear.
    Apgar BS; Brotzman G
    Am Fam Physician; 1999 May; 59(10):2794-801. PubMed ID: 10348071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colposcopy, cytology and HPV-DNA testing in HIV-positive and HIV-negative women.
    Torrisi A; Del Mistro A; Onnis GL; Merlin F; Bertorelle R; Minucci D
    Eur J Gynaecol Oncol; 2000; 21(2):168-72. PubMed ID: 10843478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and outcome of acquisition of human papillomavirus infection in women with normal cytology--a population-based cohort study from Taiwan.
    Chao A; Chang CJ; Lai CH; Chao FY; Hsu YH; Chou HH; Huang HJ; Jung SM; Lin CT; Cheng HH; Huang CC; Yang JE; Chang TC
    Int J Cancer; 2010 Jan; 126(1):191-8. PubMed ID: 19585574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women.
    Wang C; Wright TC; Denny L; Kuhn L
    J Infect Dis; 2011 Feb; 203(4):479-86. PubMed ID: 21216869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.
    Moodley JR; Constant D; Hoffman M; Salimo A; Allan B; Rybicki E; Hitzeroth I; Williamson AL
    BMC Cancer; 2009 Aug; 9():275. PubMed ID: 19664216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.